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Abstract
Hair is important for thermoregulation, physical protection, sensory activity, seasonal camouflage, and social interactions.
Hair is generated in hair follicles (HFs) and, following morphogenesis, HFs undergo cyclic phases of active growth (anagen),
regression (catagen), and inactivity (telogen) throughout life. The transcriptional regulation of this process is not well
understood. We show that the transcription factor Lhx2 is expressed in cells of the outer root sheath and a subpopulation of
matrix cells during both morphogenesis and anagen. As the HFs enter telogen, expression becomes undetectable and
reappears prior to initiation of anagen in the secondary hair germ. In contrast to previously published results, we find that
Lhx2 is primarily expressed by precursor cells outside of the bulge region where the HF stem cells are located. This
developmental, stage- and cell-specific expression suggests that Lhx2 regulates the generation and regeneration of hair. In
support of this hypothesis, we show that Lhx2 is required for anagen progression and HF morphogenesis. Moreover,
transgenic expression of Lhx2 in postnatal HFs is sufficient to induce anagen. Thus, our results reveal an alternative
interpretation of Lhx2 function in HFs compared to previously published results, since Lhx2 is periodically expressed,
primarily in precursor cells distinct from those in the bulge region, and is an essential positive regulator of hair formation.
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Introduction
Hair develops in hair follicles (HFs) and embryonic develop-
ment of HFs (morphogenesis) is initiated between embryonic days
12 (E12) to E15, and is regulated by continuous epithelial-
mesenchymal interactions between epidermal and dermal cells
[1–3]. The first morphological sign of HF morphogenesis is a
thickening of the epithelial cell layer leading to the formation of a
placode. The placode induces a dermal condensation in the
underlying mesenchyme that signals to placodal cells to proliferate
and grow down into the dermis forming the primary hair germ
(HG), followed by the formation of the hair peg. Subsequently, at
the bulbous peg stage, the dermal condensate forms the dermal
papilla (DP) as it becomes enveloped by follicular epithelial cells
[2]. At this stage the proliferating and differentiating epidermal
matrix cells adjacent to the DP start to generate the different layers
of the HF consisting of the medulla, cortex and cuticle of the hair
shaft, and the cuticle, Huxley’s layer and Henle’s layer of the inner
root sheath (IRS). The IRS is surrounded by a distinct outer layer
of outer root sheath (ORS) cells consisting of a layer of epidermal
cells continuous with the epidermis [3,4].
After birth, HFs cycle through stages of active growth (anagen),
regression (catagen) and inactivity (telogen) [2]. The periodic
growth and rest of the HF reflects the migration, proliferation
and differentiation of multipotent HF stem cells suggested to be
located primarily in the bulge region of the ORS [5]. Multipotent
stem cells have also been detected outside of bulge region in
the lower part of whisker HFs [6], and the matrix in pelage HFs
is suggested to contain restricted self-renewing stem cell for each
inner structure [7]. Whether these observations reflect differences
in stem cell migration and differentiation between whisker and
pelage HF remains to be elucidated. The onset of anagen is
characterised by the initiation of cell proliferation in the
secondary HG adjacent to the DP in the proximal part of the
HF [8], leading to the invasion of the elongating HF into
subcutaneous tissue. This process is accompanied by the
differentiation of the matrix cells in the hair bulb leading to the
formation of the hair shaft and the IRS. In pigmented animals
melanins are synthesised by melanocytes located close to the
forming hair shaft and this process occurs exclusively during
anagen [9]. During the following catagen phase, hair shaft
production stops since proliferation and differentiation is dramat-
ically reduced leading to a regression of the HF. Catagen is
followed by telogen which is characterised by a minimal signalling
exchange between the DP and follicular keratinocytes [10].
Numerous signalling pathways have been implicated in the
regulation of the HF and considerable overlap in the pathways
promoting both HF morphogenesis and the anagen stage of
postnatal HF cycling has been revealed [3]. Signalling induced by
Sonic hedgehog (Shh) and Wnts are indispensable for HF
morphogenesis and the anagen phase of HF cycle [11–14]. Active
Wnt signalling leads to stabilization and nuclear translocation of
cytoplasmic b-catenin that activate transcription of specific target
genes together with the Lef1/Tcf proteins [15]. Activation of
hedgehog signalling occurs upon ligand-binding to Patched (Ptc)
that subsequently releases its inhibitory effect on Smoothened
(Smo) leading to transcription of specific target genes by the Gli
family of transcription factors [16]. Inhibition of Bone morpho-
genetic protein (BMP) signalling by Noggin (Nog) is important for
both morphogenesis and anagen induction [17,18].
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intracellular signals that are transmitted to the nucleus, where
the activation of specific transcription factors establish and
propagate proper epithelial-mesenchymal interactions during
organ generation and regeneration. Therefore, it is important to
identify and characterize the transcription factors that are critically
involved in the development of HF as well as the regulation of HF
cycling to further elucidate epithelial-mesenchymal interactions
specific for HF morphogenesis and cycling. One class of
transcription factors, the LIM-homeodomain family, regulates
many important developmental processes such as asymmetric cell
division, tissue specification and differentiation of specific cell types
[19]. One member of this gene family, Lhx2 (previously LH2,
LH2A), was first identified as a gene specifically expressed in pre-B
cell lines and independently isolated as a transcription factor
binding to the glycoprotein hormone a-subunit promoter [20,21].
Lhx2 has been shown to be essential in various epithelial-
mesenchymal interactions as well as in the regulation of different
progenitor/stem cell populations [20,22–27], revealing its impor-
tance in regulating fundamental processes important for organ/
tissue generation and regeneration.
Since Lhx2 plays an important role in a variety of epithelial-
mesenchymal interactions and in the regulation of various stem/
progenitor cell populations, we analysed the expression pattern
and function of Lhx2 in the HF. Based on mRNA expression,
Lhx2 is expressed from an early stage of morphogenesis and
eventually becomes restricted to the ORS and a subpopulation of
the matrix cells located in the proximal part of the hair bulb.
During postnatal HF cycling Lhx2 expression reveals a similar
pattern and presence of Lhx2 protein in matrix cells and in cells
scattered in the ORS was confirmed. Moreover, Lhx2 expression
is associated with the anagen phase and was also primarily
expressed by precursor cells outside of the bulge region. These
results indicate that Lhx2 is involved in anagen initiation/
progression and morphogenesis and contradict previously pub-
lished data where Lhx2 protein was only detected in stem cells in
the bulge region [27]. Rhee et al. also suggested that Lhx2 was
important for maintaining quiescent stem cells and not involved in
their differentiation. However, by using mouse models where Lhx2
expression could be conditionally inactivated in postnatal HFs, or
significantly reduced during morphogenesis, we could confirm that
Lhx2 is important for both anagen and morphogenesis progres-
sion. Furthermore, by using a mouse model where Lhx2
expression could be induced in postnatal HFs, we also showed
that Lhx2 expression was sufficient to induce anagen. Thus, cyclic
expression of Lhx2 in HFs regulates hair formation.
Results
Expression of Lhx2 during HF morphogenesis and
postnatal cycling
To elucidate the expression pattern of Lhx2 in detail we used in
situ hybridization analysis of HFs during different stages of
morphogenesis. Lhx2 starts to be expressed in patches of basal
epidermal cells prior to any obvious formation of a dermal
condensate in the underlying dermis (Stage 0 of HF morphogen-
esis, see [28]) (Figure 1A). Lhx2 is subsequently expressed in the
placode when the epidermal thickening and the adjacent dermal
condensate have formed (Stage 1) (Figure 1B), and in the
downward growing primary HG (Stage 2–3) (Figure 1C). This
expression pattern of Lhx2 mRNA in the developing HF is in
agreement with what has been reported previously [27]. At the
epithelial peg stage (Stage 4) Lhx2 is expressed by most cells in the
epithelial portion of the developing HF (Figure 1D), and we have
no evidence for higher expression at the leading edge of the HF as
previously reported [27]. At the stage when the concentric layers
of the HF are initially formed (bulbous peg, Stage 5), Lhx2
expression becomes down-regulated in the differentiated cells in
the IRS (Figure 1E). During the postnatal phase of morphogenesis
when the HFs are fully developed and the hair shaft has erupted
through the skin surface (Stage 8), Lhx2 expression is maintained
predominantly in the epidermal matrix cells located at the most
proximal portion of the hair bulb and Lhx2
+ cells are also scattered
within the ORS (Figure 1F). A similar expression pattern is also
seen during whisker follicle morphogenesis (Figure S1A). This
expression pattern of Lhx2 has not been described previously and
we did not observe an enrichment of Lhx2 expressing cells in the
upper ORS at the presumptive bulge region [27].
In situ hybridization analysis of postnatal HFs in full anagen
(Sub-stage VI, [29]) showed that Lhx2 expression was primarily
detected in matrix cells in the proximal part of the bulb region and
in cells scattered in the ORS (Figure 1G). This expression pattern
is almost identical to that during late morphogenesis (Figure 1F),
and is also similar to the expression pattern in adult whisker
follicles which are characterised by an extended anagen (Figure
S1B) [30]. We also detected Lhx2 protein in the nucleus of cells
located in the proximal part of the hair bulb and in cells scattered
in the ORS in anagen HFs (Figure 1H and 1I). The Lhx2 protein
appears to be more stable compared to Lhx2 mRNA since the
protein can also be detected in matrix cells as they differentiate
and move distally in the hair bulb, whereas the mRNA is enriched
in the cells from where the matrix cells originate in the proximal
part of the bulb (Figure 1H and 1G). Persistence of Lhx2 protein
after mRNA down-regulation during differentiation has been
observed previously in the olfactory epithelium [24]. Thus, the
presence of Lhx2 mRNA in the HF is a reliable indicator of
functional expression of Lhx2. However, Lhx2 expression was not
detected at the time when the HFs had entered telogen at 7–8
weeks of age, (Figure 1J), suggesting a cyclic expression pattern of
Lhx2 in postnatal HFs.
To further investigate the fluctuations in Lhx2 expression we
determined the expression pattern around the time of telogen-
anagen transition. Since induction of the second postnatal anagen
was difficult to predict in our control animals (Table S1), we
analysed HFs during the first postnatal telogen and the different
Sub-stages of the subsequent and first postnatal anagen in 3–4
Author Summary
Hair is generated in hair follicles, complex mini-organs in
the skin that are devoted to this task. All hair follicles are
generated during embryonic development. The hair
follicles generate a new hair shaft by cycling through
stages of regression, rest, and growth continuously
throughout life. The length of the growth phase deter-
mines the length of the hair. The reason(s) for this
complicated regulation of hair growth is not clear, but it
has been suggested that it may accommodate seasonal
variations in hair growth. In this study we have identified
the transcription factor Lhx2 as an important regulator of
hair formation. The Lhx2 gene is active during the growth
phase of the hair follicle and is turned off during the
resting phase. We confirm that Lhx2 is functionally
involved in hair formation, since hair follicles where Lhx2
has been inactivated are unable to make hair. Moreover,
activation of the Lhx2 gene in hair follicles induced the
growth phase and hence hair formation. Thus, Lhx2 is an
important regulator of hair growth.
Lhx2 Is Required for Hair Formation
PLoS Genetics | www.plosgenetics.org 2 April 2010 | Volume 6 | Issue 4 | e1000904Figure 1. Lhx2 is expressed from early stages of morphogenesis and becomes restricted to the proximal part of the hair bulb and
the ORS in fully developed HFs. Lhx2 expression analysed by in situ hybridization (A–G,J) and immunohistochemistry (H-I) of tissue sections of
HFs at different stages of morphogenesis (A–F) and in postnatal anagen (G–I) and telogen (J). (A) Lhx2 expression in basal keratinocytes at the pre-
germ stage (Stage 0) prior to any obvious morphological change of the keratinocytes or the underlying dermis. (B) HF at the hair germ or placode
stage (Stage 1) showing Lhx2 expression in the keratinocytes located at the local thickening of the epidermis. Reorganisation of mesenchymal cells in
the dermis beneath the placode is indicative of formation of a dermal condensate. (C) HF at germ/peg stage (Stage 2–3) of HF morphogenesis. (D) HF
at the peg stage (Stage 4), Lhx2 is expressed in the entire epithelial portion of the HF. (E) HF at the bulbous peg stage (Stage 5–6) when formation of
the IRS has begun. Lhx2 is still widely expressed in outer layers of the HF and in the proximal extension the ORS in the future hair bulb whereas
Lhx2 Is Required for Hair Formation
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(Figure 2A and 2D; Table S1), Lhx2 expression could not be
detected in any HF (Figure 2B and 2C; Figure S3A), similar to
what was observed in HFs in telogen in 7–8 weeks old mice
(Figure 1J). In slightly older animals ($3 weeks and 4 days) HFs in
several individuals have initiated anagen (Table S1). However,
some animals at this age that neither show any obvious
morphological transition to anagen, nor express anagen-specific
genes such as Shh (Figure 2E and 2I), revealed distinct expression
of Lhx2 in the secondary HG adjacent to the DP (Figure 2F–2H;
Figure S3B). HF stem cells located in the bulge area express
CD34, whereas the cells in the secondary HG are CD34
2
(Figure 2B and 2F) [31]. Few, if any, of the Lhx2 expressing cells
are CD34
+ since they appear as separate cell populations
(Figure 2F). In the early stages of anagen when Shh is expressed
but prior to any pigment deposition (e.g. anagen Sub-stages I-II.
Figure 2J and 2M), Lhx2 is expressed both by cells in the secondary
HG, where the first proliferating cells are located during anagen
induction [8], and by the future matrix cells surrounding the DP
(Figure 2K and 2L; Figure S3C). Although there is a sharp
boundary where Lhx2 mRNA is present or absent between the
secondary HG and the bulge region, we can detect Lhx2 protein
in a few cells in the lower part of the bulge region as well as in the
secondary HG (Figure 2K’). In the subsequent Sub-stage of
anagen (maintained Shh expression) when melanocytes deposit
pigment (Sub-stage IIIa-c, Figure 2N and 2Q), the matrix cells in
the proximal part of the bulb and cells in the ORS express Lhx2
whereas expression is turned off in the IRS cells (Figure 2O and
2P; Figure S3D), similar to the expression pattern during early HF
morphogenesis (compare Figure 2P and Figure S3D to Figure 1D
and 1E). At later Sub-stages of anagen (Sub-stages IV-VI with
maintained Shh expression, Figure 2R and 2U) Lhx2 expression is
maintained in the ORS (Figure 2S and 2T; Figure 1G and 1H)
and in matrix cells in the most proximal part of the bulb (Figure 2S’
and 2T’; Figure 1G–1I), similar to expression pattern during Stage
8 of HF morphogenesis (Figure 1F). Also during anagen most of
the Lhx2
+ cells are CD34
2 as they represent separate cell
populations (Figure 2K, 2O, 2S, and 2S’). Thus, during postnatal
HF cycling, Lhx2 expression is initiated in a distinct subpopulation
of CD34
2 epidermal progenitor cells in the secondary HG during
late telogen immediately prior to anagen induction and the
expression is maintained in the transient portion of the HF
throughout anagen. In contrast to previously published results
[27], the anagen-associated expression during adult HF cycling,
and the similarity of this expression pattern to that during HF
morphogenesis, suggest that Lhx2 regulate hair generation and
regeneration.
Lhx2 is required for postnatal hair formation
We have shown that Lhx2 expression is normally associated with
the anagen phase of postnatal HF cycling and we therefore wanted
to elucidate whether Lhx2 is necessary for anagen initiation
and/or progression. To address this issue we obtained two mouse
strains in which Lhx2 exons have been flanked by loxp sites, e.g.
floxed Lhx2 alleles (Lhx2
flox) (Figure S4B, and [32]), in order to
conditionally inactivate the Lhx2 gene by expression of the Cre
recombinase [32]. The Lhx2
flox mice were bred into mice harbouring
the null allele of Lhx2 (Lhx2
2) [22], and into transgenic mice
ubiquitously expressing a fusion protein between the Cre recombi-
nase and the ligand binding domain of the Estrogen Receptor (CreER)
[33], to generate CreER:Lhx2
flox/flox, CreER:Lhx2
flox/-, Lhx2
flox/flox and
Lhx2
flox/- mice. Application of Tamoxifen (Tx) to the skin leads to
nuclear translocation of the CreER fusion protein and conditional
inactivation of the Lhx2 gene in HFs in the CreER:Lhx2
flox/flox and the
CreER:Lhx2
flox/- mice. The Lhx2 gene in the Lhx2
flox/flox and the
Lhx2
flox/- mice is unaffected by this treatment and were used as a
control. The skin on the back of these mice was shaved and treated
with Tx during the first postnatal telogen at approximately 3 weeks
of age (Figure S2). Initiation and progression of the first postnatal
anagen starting around 4 weeks of age was subsequently analysed
(see Figure S2). Most of the Tx-treated CreER:Lhx2
flox/- and
CreER:Lhx2
flox/flox mice did not re-grow their hair coat on the
shaved area (6/8) whereas all the control animals did (9/9)
(Figure 3A), revealing that Lhx2 is required for postnatal hair
regeneration. Histological analysis of the HFs where Lhx2 was
inactivated showed that anagen is initiated similar to control
animals and progress to anagen Sub-stage III (Figure 3B and 3D),
but whereas the control HFs develop normally the mutant HFs are
unable to develop beyond Sub-stage III and assemble a normal hair
shaft(Figure 3Cand3E).HFsoutsideofthe Tx-treatedareainthese
mice assembled hair shafts that were indistinguishable from control
HFs (Figure 3F). To confirm the inactivation of the Lhx2 gene we
performed in situ hybridisation using the full length Lhx2 cDNA as a
probe which has been shown to hybridise to mRNA expressed from
both the WT allele as well as to the inactivated Lhx2 allele [34,35],
and an exon 2-specific probe that only hybridises to the WT mRNA
as this exon is deleted in both the conditionally inactivated Lhx2
flox
alleles and in the Lhx2
- allele (Figure S4B, [22,32]). As expected,
cells in control HFs in anagen expressed mRNA hybridising to both
probes (Figure 3G, left panels), whereas cells in anagen HFs, in
which Lhx2 should be conditionally inactivated, expressed a
truncated mRNA hybridising exclusively to the full length probe
and hence lacking exon 2 (Figure 3G, right panels). Significant
reduction of Lhx2 protein in the ORS and the hair bulb could also
be observed in the HFs where Lhx2 had been conditionally
inactivated (Figure 3H), confirming that the cells expressing the
truncatedmRNAareunabletogenerate afunctionalprotein.These
results confirmed that the Lhx2 gene has been inactivated in the Tx-
treated CreER:Lhx2
flox/- and CreER:Lhx2
flox/flox mice. Two Tx-treated
CreER:Lhx2
flox/flox mice started to re-grow some hair one week later
compared to the control animals. Also skin from these individuals
had HFs with arrested development, but there were numerous HFs
containing cells expressing the control allele since the mRNA
hybridised to both the full length probe as well as the exon 2-specific
probe (Figure S5). None of the Tx- treated CreER:Lhx2
flox/- mice
re-grew their hair, revealing that conditional inactivation of the
Lhx2 gene was more efficient in these mice compared to the
CreER:Lhx2
flox/flox mice, where a few cells retaining the control allele
could rescue hair formation to some extent. Thus, Lhx2 is critically
involved in hair formation by regulating anagen progression.
expression is turned off in cells in the forming IRS. (F) Fully developed HFs when the hair shaft has erupted through the epidermis (Stage 8). Lhx2 is
expressed in the proximal part of the hair bulb (arrows) and in cells scattered in the ORS (arrow heads). (G) Analysis of Lhx2 expression in HFs during
postnatal anagen Sub-stage VI revealing expression in the proximal part of the hair bulb (arrows) and in cells scattered in the ORS (arrow heads). (H,I)
Immunohistochemical analysis of Lhx2 expression in anagen Sub-stage VI HFs revealing presence of nuclear Lhx2 protein in cells in proximal part of
the hair bulb and in matrix cells (H, arrows) and in cells scattered in the ORS (H and I, arrow heads). (J) Analysis of Lhx2 expression in adult HFs in the
extended telogen in 7–8 weeks old mice revealing no detectable expression. ch, club hair; dc. dermal condensate; d, dermis; e, epidermis. Scale bars,
(A–I) 50 mm; (J) 100 mm.
doi:10.1371/journal.pgen.1000904.g001
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2/2 mouse forebrain has been suggested
to be due to lack of proliferating progenitor cells [22]. To analyse if
the HF phenotype is solely due to lack of proliferating progenitor
cells, we analysed the expression of the S-phase-specific histone
gene Hist1h3c [36,37]. As expected Hist1h3c expression could not
be detected in HFs in telogen whereas it is expressed in the
proximal part of the hair bulb and in matrix cells in HFs in anagen
(Figure S6A and S6B; Figure 3I), where the proliferating
progenitor cells are located. Numerous cells expressing Hist1h3c
could also be observed in a similar pattern in the HFs where Lhx2
had been conditionally inactivated 1–2 weeks after the control
mice re-grew their hair (Figure 3I; Figure S6C). Thus, although we
have not quantified the level of expression of Hist1h3c or quantified
the number of proliferating cells, the developmental arrest at
anagen Sub-stage III in mutant HFs cannot solely due to the fact
that the progenitor cells are unable to proliferate.
The presence of a significant number of proliferating progenitor
cells in mutant HFs suggested that the signalling pathways critical
for anagen initiation/progression were relatively unperturbed. To
address this issue we analysed the expression of various genes
encoding mediators of such pathways. No obvious differences in
the expression of mediators of hedgehog signalling was observed
since the ligand Shh, the signal transducer Smo, and the receptor
and universal target of hedgehog signalling Ptc1 were equally
expressed in control and mutated HFs (Figure 3J). Moreover, the
basal components of the canonical Wnt signalling pathway were
also present, since both control and mutated HFs accumulated
activated (i. e. dephosphorylated) b-catenin, and expressed Lef1,
the transcriptional effecter of activated b-catenin (Figure 3J). Thus,
inactivation of Lhx2 appears not to have a major impact on the
hedgehog or Wnt signalling pathways.
Since the mutated HFs contained proliferating cells and had no
obvious defects in signalling pathways important for anagen
progression, we wanted to elucidate if the mutated HFs are either
completely blocked or delayed in their development. To address
this issue we analysed mice with mutated HFs that had not re-
grown any hair at 9 weeks of age. At 9 weeks of age most control
animals have entered telogen (Table S1) and thus do not express
Lhx2, Shh,o rHist1h3c (Figure 1J; Figure 2B and 2C; Figure 2D and
2I; Figure S6A). Although many HFs have initiated hair shaft
formation in the 9 week old conditional mutants, we rarely find
any HFs that have developed beyond anagen Sub-stage III and
some of the formed hair shafts appear distorted (Figure 3K).
Moreover, all HFs contain cells expressing the truncated Lhx2
allele since the mRNA hybridised only to the full length probe
whereas it does not hybridise to the exon 2-specific probe
(Figure 3K). Also the anagen-specific marker Shh and the
proliferation-specific marker Hist1h3c are expressed in the
mutated HFs (Figure 3K). These results suggest that the HFs
where Lhx2 were efficiently inactivated are maintained in an
anagen-like stage but are unable to assemble a normal full length
hair shaft even after an extended period of time. Thus, Lhx2 does
not primarily regulate the proliferation of HF progenitor cells but
rather appears to regulate the patterning/differentiation of HF
progenitor cells.
Lhx2 is required for HF morphogenesis
Since there is significant overlap between the signalling
pathways promoting HF morphogenesis and the anagen stage
[3], we wanted to elucidate if Lhx2 is also important for HF
morphogenesis. A significant decrease in the number of HFs in
Lhx2
2/2 embryos has been reported [27], indicating that Lhx2
play a role in HF morphogenesis. However, since the lethality of
Lhx2
2/2 embryos at E15–17 [22] coincides with and even
precedes the onset of pelage HF morphogenesis, it is difficult
to ascertain the precise role of Lhx2 in HF morphogenesis in
Lhx2
2/2 embryos. To further investigate this we generated a
mouse strain harbouring a hypomorphic allele of Lhx2 denoted
Lhx2
Neo (Figure S4A). Mouse embryos homozygous for this allele
(Lhx2
Neo/Neo mice) develop an eyeless phenotype similar to the
Lhx2
2/2 mouse embryos (Figure S4C) confirming that Lhx2
expression was significantly reduced in the Lhx2
Neo/Neo embryos.
However, Lhx2 expression is detected in the Lhx2
Neo/Neo embryos
revealing that it is not a null allele (Figure 4D). Since the liver was
less affected in these animals compared to Lhx2
2/2 embryos (data
not shown), the expected number of viable Lhx2
Neo/Neo embryos
were obtained at late gestation. Thus, this mouse strain allowed us
to follow pelage HF morphogenesis up to a stage when it is well
established [2,38]. Back skin of all E16.5 Lhx2
Neo/Neo embryos
contained fewer HFs compared to control animals (Figure 4A and
4C), which is in agreement with the number found in Lhx2
2/2
embryos at a similar gestational age [27]. Moreover, the HFs that
did develop in the Lhx2
Neo/Neo embryos had a distinct DP but
appeared to be developmentally arrested prior to the epithelial peg
stage (Stage 4) compared to the HFs in control animals (Figure 4A).
At E18.5 the difference in number of HFs between control and
Lhx2
Neo/Neo embryos was more striking since HF density did not
increase between E16.5 and E18.5 in Lhx2
Neo/Neo embryos
(Figure 4B and 4C), whereas it increased by 75% in the control
embryos (Figure 4C). Moreover, many HFs in E18.5 Lhx2
Neo/Neo
embryos appeared to be developmentally arrested at the same
stage as those in the E16.5 embryos (Figure 4A and 4B), similarly
Figure 2. Lhx2 expression is associated with anagen during postnatal HF cycling and is not transcribed by CD34
+ bulge cells. HFs at
different Stages and Sub-stages of postnatal cycles analysed by Hematoxylin/Eosin (H/E) staining (A,E,J,N,R), CD34 immunofluorescence (B,F,K,O,S,S’),
Lhx2 in situ hybridisation (B,C,F,H,K,L,O,P,S,S’,T,T’), Lhx2 immunofluorenscence (K’), Shh in situ hybridisation (D,I,M,Q,U) and alkaline phosphatase (AP)
staining (G). The CD34 immunoflouresence and Lhx2 in situ hybridisation are performed on the same section and the Lhx2 in situ signal (black) has
been pseudocoloured red on the DAPI stained sections (B,F,K,O,S,S’). AP staining distinguishes the DP from the secondary HG where Lhx2 is initially
expressed in late telogen (F–H). Shh expression confirms the stage of the HF cycle since Shh is only expressed during anagen. (A–D) HFs in early
telogen, CD34
+ cells are located in the bulge (Bu) area (B) and no Lhx2 expression (B and C) or Shh expression (D) can be detected at this stage. (E–I)
HFs in late telogen, CD34
+ cells are located in the bulge area (F) whereas Lhx2 is expressed by cells in the secondary hair germ (2uHG) located
between the bulge area and the AP
+ cells in the DP (F–H). There is no overlap in Lhx2 and CD34 expression (F). Shh is not expressed confirming that
the HFs are in telogen (I). (J–M) HFs in anagen Sub-stages I-II as no deposition of pigment is detected (J). CD34
+ cells are located in the bulge area
whereas Lhx2 is expressed in the secondary HG and the extended part of the HF enveloping the DP (K and L). Immunohistochemical analysis of Lhx2
protein reveal presence of Lhx2 in the 2uHG (K’, arrows) as well as a few cells in the lower part of the bulge region (K’, arrow heads), despite absence
of Lhx2 mRNA in this part of the HF. Shh is expressed confirming that anagen has commenced (M, arrow). (N–Q) HFs in anagen Sub-stage III as
deposition of pigment has started (N). CD34
+ cells are located in the bulge area (O) whereas Lhx2 expression is detected in the lower transient part of
the HF (O,P). Shh is expressed confirming ongoing anagen (Q, arrows). (R–U) HFs in anagen Sub-stage IV-V as the hair shaft has reached the hair canal
(R). CD34
+ cells are located in the bulge area whereas Lhx2 expression is detected in the proximal part of the hair bulb (S’ and T’, arrow) and in cells
scattered in the ORS (S and T, arrow). Shh is expressed confirming ongoing anagen (U, arrows). * indicates melanin deposition. Scale bars, 50 mm.
2uHG, secondary hair germ; Bu, bulge; DP, dermal papilla; IRS, inner root sheath.
doi:10.1371/journal.pgen.1000904.g002
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inactivated in postnatal HFs (Figure 3E). To investigate whether
loss of Lhx2 affected signalling pathways critically involved in HF
morphogenesis, we analysed expression of various genes encoding
mediators of such pathways. Similar to the postnatal HFs where
Lhx2 had been conditionally inactivated, there was no obvious
difference between control and Lhx2
Neo/Neo HFs in expression levels
in for components of the hedgehog signalling pathways (Smo, Shh
and Ptc1), the canonical Wnt signalling pathway (Lef1) or BMP
signalling pathway (BMP4 and Noggin) (Figure 4D). The
distribution of E-cadherin (E-cad) in interfollicular epidermis is
similar in control and Lhx2
Neo/Neo skin at E16.5 (Figure 4D). In
summary, the use of a hypomorphic loss-of-function model for
Lhx2 has allowed us to follow HF development to a much later
stage of embryonic development compared to Lhx2
2/2 embryos.
By using this novel loss-of-function model we have been able to
Figure 4. Reduced expression of Lhx2 hampers HF morphogenesis. (A,B) AP staining of skin sections of E16.5 embryos (A) and E18.5
embryos (B) revealing the number of HFs in skin of control embryos (upper panels) compared to skin in Lhx2
Neo/Neo embryos (lower panels). (C)
Estimation of HF density based on the AP staining of skin of E16.5 embryos (left) and E18.5 embryos (right) comparing control embryos to Lhx2
Neo/Neo
embryos. Data are presented as average 6 SD. *p,0.005. **p,0.0001 (Student’s t-test). (D) Skin sections of E16.5 embryos were analysed by in situ
hybridization for expression of the indicated genes encoding mediators of signaling pathways involved in HF morphogenesis (arrow heads), and
analysed by immunohistochemistry for expression of E-cad in epidermis comparing control embryos (upper panels) to Lhx2
Neo/Neo embryos (lower
panels). Scale bars, 100 mm.
doi:10.1371/journal.pgen.1000904.g004
Figure 3. Lhx2 is required for anagen progression. (A) A Lhx2
flox/- control mouse (upper panel) and a CreER:Lhx2
flox/- mouse (lower panel) that
were shaved and treated with Tx during the first postnatal telogen and analysed during late first postnatal anagen. Hair have re-grown on the shaved
area in the control mouse but not in the CreER:Lhx2
flox/- mouse. (B,C) H/E staining of sections of skin from Tx-treated control mice in early anagen (B,
Sub-stage III) and late anagen (C, Sub-stage VI). (D–F) H/E staining of sections of skin from Tx-treated CreER:Lhx2
flox/- mice within the Tx-treated area
(D,E) and outside of the Tx-treated area (F). Mutant HFs initiated anagen and developed to Sub-stage III similar to control mice (D, early anagen), but
these HFs were arrested at this stage and were unable to assemble a normal hair shaft (E, late anagen). Hair shafts developed in HFs outside of the Tx-
treated area in the CreER:Lhx2
flox/- mice (F). (G) In situ hybridization analyses of Lhx2 expression in HFs in anagen in Tx-treated control animals (upper
panels) and CreER:Lhx2
flox/- animals (lower panels) using a full length (fl) Lhx2 cDNA probe (left panels) or a probe restricted to exon 2 (right panels).
Control HFs revealed hybridization to both probes whereas the mutated HFs only hybridized to the full length probe confirming the expression of
the truncated Lhx2 mRNA in the HFs where Lhx2 has been conditionally inactivated. (H) Immunohistochemical analysis of Lhx2 expression using and
anti-Lhx2 antibody in control HFs (upper panel) and in HFs where Lhx2 has been conditionally inactivated (lower panel). (I) In situ hybridization
analysis of expression of the S-phase-specific gene His1h3c in control anagen HFs (upper panel) and in anagen HFs where Lhx2 has been conditionally
inactivated (lower panel). (J) Comparison of gene expression using in situ hybridization of the indicated genes between control anagen HFs (upper
panel) and anagen HFs where Lhx2 has been conditionally inactivated (lower panel). Comparison of accumulation of the activated form of b-catenin
(brown staining) in control HFs (upper right panel) and in HFs where Lhx2 has been inactivated (lower right panel) using an antibody specific for the
dephosphorylated form of b-catenin. (K) Morphological and gene expression analyses of a Tx-treated CreER:Lhx2
flox/- mouse that have not re-grown
the hair at 9 week of age. H/E staining of sections of skin revealing that normal hair shafts are not assembled (left panel, compare to control skin in C).
Cells in the mutant HFs express Lhx2 mRNA that hybridize to the full length Lhx2 probe (fl. arrows) but not the exon-2 specific probe revealing that
the Lhx2 gene is completely inactivated. Cells in mutant HFs also express the anagen-specific gene Shh (arrows) and the S-phase-specific gene
His1h3c revealing the presence of proliferating cells (arrows). * indicates melanin deposition. Scale bars 100 mm.
doi:10.1371/journal.pgen.1000904.g003
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the significant reduction in number of HFs suggests that Lhx2 also
play a role in HF induction.
Lhx2 expression is sufficient to induce anagen
It has been previously reported that over-expression of Lhx2 in
early embryonic epidermis has no effect on HF morphogenesis
[27]. This could be explained by the already high level expression
of endogenous Lhx2 in the developing HF (Figure 1A–1E), upon
which additional Lhx2 expression would have little effect. We
therefore reasoned that investigation of the function of Lhx2 in HFs
would be helped by analysing the effect of transgenic expression of
Lhx2 when the endogenous gene is turned off during telogen
(Figure 1J). To address this issue we developed a mouse model
where we could induce Lhx2 expression in the epidermal portion
of postnatal HFs. We utilised an expression system based on the
Z/AP double reporter vector [39], where a floxed allele of b-Geo
(encoding a b-galactosidase-Neomycin fusion protein) is followed
by an expression cassette consisting of the Lhx2 cDNA, an internal
ribosomal entry site (IRES) and green fluorescent protein (GFP)
cDNA (Figure S7A). A Z/Lhx2-GFP founder mouse strain with
high b-Galactosidase (b-Gal) activity in the epithelial part of HFs
during telogen and in ORS cells during anagen was chosen for
further breeding (Figure S7B and S7C). Thus, DNA recombina-
tion by the Cre recombinase (e.g. following CreER expression and
Tx treatment) will delete the b-Geo gene and induce expression of
Lhx2-GFP primarily in the b-Gal
+ cells (Figure S7).
To analyse the effect of Lhx2 expression on HF cycling we
applied Tx onto shaved back skin of 5 week old control mice and
Z/Lhx2-GFP:CreER double transgenic mice and analysed the mice
at 8–9 weeks of age when HFs should be in telogen (Figure S2).
Since most animals will complete an anagen-catagen-telogen
transition between the Tx treatment and the time of analysis
(Table S1; Figure S2), this experimental approach would avoid
confounding effects of the shaving procedure and/or of the Tx
treatment. Moreover, this approach allowed us to analyse if
transgenic Lhx2 expression influence the transition from anagen to
telogen, and how it affects HFs in the extended telogen phase. HFs
in all Tx-treated Z/Lhx2-GFP:CreER mice were in anagen at 9
weeks of age as determined by size, morphology, melanin
deposition and Shh expression (Figure 5A and 5A’; Table 1),
whereas HFs in almost all control mice were in telogen as expected
at this age (Figure 5B and 5B’; Table 1; Table S1). Moreover, HFs
that were outside of the Tx-treated area on Z/Lhx2-GFP:CreER
mice remained in telogen (Figure 5C and 5C’).
An extension of the growth phase of the HF by one week will
generate noticeably longer hair in mice [40]. If our experimental
set-up maintained anagen from Tx-treatment until the time of
analysis, the length of anagen would have been extended by .2
weeks and hence lead to considerably longer hair. However, we
did not observe any obvious increase in hair length in the Tx-
treated Z/Lhx2-GFP:CreER mice (data not shown), suggesting that
our experimental approach did not prolong the anagen phase but
rather prematurely induced anagen in the following extended
telogen. To further address this issue we analysed HFs in Tx-
treated double transgenic mice closer to the time for anagen-
catagen-telogen transition to elucidate whether animals expressing
transgenic Lhx2 could enter telogen. At this time (8 weeks and 2–4
days old) the HFs were in telogen in one animal (Figure 5E and
5E’, Table 1) whereas the remaining mice had the HFs in anagen
(Figure 5D, 5D’, 5F, and 5F’; Table 1). The HFs in all control
mice for these time points were in telogen (Figure 5G and 5G’;
Table 1). Thus, HFs where Lhx2 expression had been induced
were able to enter telogen at the same time as control HFs at
approximately 7–8 weeks of age, showing that the former HFs
prematurely initiated anagen as they all were in anagen by 9 weeks
of age (Table 1). Thus, the HFs in 89% (8/9) of the Tx-treated Z/
Lhx2-GFP:CreER mice were in anagen, whereas HFs in 98% of the
treated control animals were in telogen as expected (Table 1). The
only time we observed HFs in telogen in Tx-treated Z/Lhx2-
GFP:CreER mice was when analysed at an earlier time point close
to the expected time for the anagen-catagen-telogen transition,
suggesting that our experimental approach lead to premature
initiation of anagen.
To confirm Cre-mediated recombination of the Z/Lhx2-GFP
transgene and expression of Lhx2-GFP we analysed b-Gal activity
and GFP expression in HFs in Tx-treated Z/Lhx2-GFP:CreER mice
and control mice. Cells with robust expression of GFP were usually
enriched at the proximal part of the hair bulb in 50% of the HFs in
Tx-treated double transgenic mice (Figure 5H) whereas no GFP
expression was detected in HFs in Tx-treated Z/Lhx2-GFP controls
(Figure 5J). Numerous cells expressing endogenous Lhx2 were also
located in the proximal part of the bulb during anagen (Figure 1G
and 1H), suggesting that the cells expressing transgenic Lhx2
follow the same migration path as the cells expressing the
endogenous gene. GFP was also expressed by cells in the ORS,
which is in agreement with the distribution of the b-Gal
+ cells in
Z/Lhx2-GFP control mice (Figure 5H and 5L; Figure S7C).
Although most HFs showed GFP expression in the proximal part
of the hair bulb the distribution and number of GFP
+ cells in the
remaining HFs varied considerably (Figure 5I). Both GFP
+ and
Lhx2
+ cells were frequently detected in the IRS (Figure 5I and
5M), showing that follicular progenitor cells can migrate into the
IRS despite maintained expression of Lhx2. However, Cre-
mediated excision of b-Geo was not complete in the Tx-treated
Z/Lhx2-GFP:CreER mice since numerous b-Gal
+ cells were present
in these HFs (Figure 5K). As expected, GFP expression and b-Gal
activity appears to be mutually exclusive since cells lacking b-Gal
activity were enriched in GFP
+ regions in the proximal part of the
bulb (Figure 5K and 5H), whereas numerous b-Gal
+ cells are
located in this region in control Z/Lhx2-GFP mice (Figure 5L and
Figure S7C). Some HFs in Tx-treated Z/Lhx2-GFP:CreER mice
contained more b-Gal
+ cells which is in agreement with the
decreased number of GFP
+ cells in some HFs (Figure 5K and 5I).
Since Lhx2 expression is detected in all HFs in these mice whereas
expression of GFP is not (compare Figure 5M to Figure 5H and
5I), indicates that the endogenous Lhx2 gene is also expressed as in
normal anagen. Thus, relatively few cells expressing the Lhx2
transgene is sufficient to induce endogenous Lhx2 expression in a
cell nonautonomous manner and thereby prematurely initiate
anagen.
Discussion
We have analysed the function and expression of the LIM-
homeobox gene Lhx2 in HFs during morphogenesis and the cyclic
phases of postnatal hair growth (summarised in Figure 6). Lhx2 is
expressed in basal keratinocytes prior to the formation of the hair
placode at initiation of morphogenesis. Expression becomes
restricted to matrix cells at the proximal part of the hair bulb
and to cells in the ORS in a fully developed HF. When the HF
enters telogen Lhx2 expression becomes undetectable. However,
during late telogen Lhx2 expression re-appears in CD34
- cells
located in the secondary HG and this expression is maintained
when anagen commences. The expression observed during
morphogenesis is thereafter reiterated during progression of
anagen. This developmental and stage-specific expression pattern
suggests that Lhx2 is involved in the generation and regeneration
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PLoS Genetics | www.plosgenetics.org 9 April 2010 | Volume 6 | Issue 4 | e1000904Figure 5. Lhx2 expression is sufficient to induce the anagen stage of the HF cycle. (A,A’) H/E staining of back skin HFs in anagen in 9 weeks
old Tx-treated Z/Lhx2-GFP:CreER mice (A) revealing Shh expression (A’). (B,B’) H/E staining of back skin HFs in telogen in 9 weeks old Tx-treated control
mice (B) revealing no Shh expression (B’). (C,C’) H/E staining of back skin HFs in telogen (C) retrieved from an area outside of the Tx-treated area in
Z/Lhx2-GFP:CreER mice revealing no Shh expression (C’). (D–G,D’–G’) Representative examples of back skin HFs in 8 week and 2 day old Tx-treated
Z/Lhx2-GFP:CreER mice where HFs in one individual are in anagen (D,D’) and in telogen in another individual (E,E’) showing that these mice also could
enter telogen at the same time as the control animals (G,G’). The HFs were in anagen also in a slightly older Tx-treated Z/Lhx2-GFP:CreER animal
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expression could either be conditionally inactivated, significantly
reduced, or switched on in the HF. The loss-of-function mouse
models revealed that Lhx2 is required for progression of both
anagen and morphogenesis and hence hair formation. The gain-
of-function mouse model showed that Lhx2 expression is sufficient
to induce anagen. The function of Lhx2 in the HF has been
addressed previously [27], concluding that Lhx2 is important for
maintaining the quiescence of the stem cells located in the bulge
region. This interpretation of Lhx2 function is difficult to reconcile
with the expression pattern and the phenotypes in the gain-of-
function and loss-of-function mouse strains reported herein. The
reasons for these discrepancies in interpretations of the function of
Lhx2 in the HF are not clear. We do, however, detect Lhx2
protein in cells in the proximal part of the bulge region, which is in
agreement with Rhee et al. [27], although we are unable to detect
Lhx2 mRNA in these cells. The functional relevance of this
observation remains to be elucidated. The different interpretation
of the function of Lhx2 could be explained by the different
approaches used to study gain-of-function and loss-of-function.
Rhee et al. [27] expressed Lhx2 under the control of the keratin-14
promoter leading to epidermal Lhx2 expression early in
embryonic development, probably prior to HF induction [41],
and when the endogenous Lhx2 gene is widely expressed in the
developing HF. We induced expression in HFs when the
endogenous gene is turned off during telogen. Rhee et al. analysed
loss-of-function by transplanting HFs from Lhx2
2/2 embryos onto
skin of nude mice, whereas we analysed intact postnatal HFs
where the Lhx2 gene had been conditionally inactivated. Rhee et al.
also showed a significantly reduced number of HFs in the
conventional Lhx2 mutant embryos, which is in agreement with
our loss of function data in embryos of the same gestational age.
However, since the Lhx2
2/2 embryos start to die in utero even prior
to initiation of HF morphogenesis, we confirmed these observa-
tions in a mouse strain harbouring a hypomorphic allele of Lhx2
(Lhx2
Neo) where HF development can be followed to a gestational
age when pelage HF morphogenesis is firmly established.
The Bulge Activation hypothesis has been the dominating
theory of induction of anagen at the expense of the HF
Predetermination hypothesis. The Bulge Activation hypothesis
suggests that stem cells in the bulge region start to proliferate after
responding to signal(s) emanating from the DP, generating
transient amplifying cells that migrate to the secondary HG and
initiate anagen [5,42]. The HF Predetermination hypothesis
suggests that the secondary HG itself contains stem cells that start
to proliferate after receiving signals from the DP without input of
transient amplifying cells from the bulge region [43,44]. This
hypothesis has been discarded mainly due to the failure to detect
slowly dividing cells, or so-called label-retaining cells (LRCs), in
the secondary HG. The observation that Lhx2 expression is
initiated in CD34
2 cells in the secondary HG, and not in CD34
+
cells in the bulge region, just prior to and at initiation of anagen fits
with the HF Predetermination hypothesis. Although we cannot
exclude that a few CD34
+Lhx2
+ cells might be present in the
bulge, the majority of the Lhx2
+ cells are CD34
2 and are located
in the secondary HG, the ORS, and in cells in the proximal part of
the hair bulb. Thus, our data strongly suggest that Lhx2 expressing
cells are involved in the expansion and patterning of the transient
portion of the HF. An alternative interpretation that would fit with
the Bulge Activation hypothesis is that Lhx2
+ cells in the secondary
HG in late telogen relay signal(s) from the DP to the cells in the
bulge region leading to the migration of these cells into the
secondary HG and hence initiation of anagen. Consequently, the
stem cells start to express Lhx2 when they have left the bulge
region and entered the secondary HG. Thus, irrespective of which
hypothesis prevails, the Lhx2
+ cells in the HG represent an
epidermal progenitor/stem cell population that is distinct from
those in the bulge region.
The CD34
+ cells in the bulge region are LRCs and many of
their stem cell properties have been based on this feature [5,31],
whereas no LRCs are present in the secondary HG [5,43]. We
show that Lhx2 is primarily expressed by CD34
2 cells and hence
Lhx2 is most probably not expressed by LRCs in the bulge region.
However, a recent study where the fate of cells expressing the
leucine-rich G protein-coupled receptor 5 (Lgr5) was analysed,
question the link between stem cells and LRCs in HFs [45]. The
Lgr5
+ cells were suggested to define a novel stem cell population
that cycles, is long lived and multipotent, contradicting the
generally held view that ‘‘true’’ stem cells are quiescent and hence
LRCs, whereas their progeny (i.e. transient amplifying cells)
actively cycle and are short-lived. The authors suggest that Lgr5
expression defines a novel stem cell population distinct from the
CD34
+ LRCs in the bulge region and argue for a reinvestigation of
the relationship between HF stem cells and LRCs. The expression
pattern of this novel stem cell marker in the HF is very similar to
that of Lhx2 since both Lgr5 and Lhx2 are expressed in the
secondary HG, in the ORS and in matrix cells in the proximal
part of the hair bulb. A significant overlap in Lhx2 and Lgr5
expression is also corroborated by Jaks et al. [45] who show that
Lhx2 is only expressed by Lgr5
+ cells in the HF. Although the
exact relationship between Lhx2 and Lgr5 expression at the
Table 1. Lhx2 expression induce anagen.
Genotype Age Anagen Telogen
Control 9 w. 3% (1/34) 97% (33/34)
Z/Lhx2-GFP:CreER 9 w. 100% (6/6{) 0% (0/6)
Control 8 w. 2–4 d. 0% (0/7) 100% (7/7)
Z/Lhx2-GFP:CreER 8 w. 2–4 d. 67% (2/3) 33% (1/3)
Control* All 2% (1/41) 98% (40/41)
Z/Lhx2-GFP:CreER All 89% (8/9{) 11% (1/9)
*Genotypes of the control mice include non-transgenic (WT), Z/Lhx2-GFP single
transgenic and CreER single transgenic animals. These control mice are also
included in Table S1.
{Chi-square analysis Z/Lhx2:CreER vs. control: p,0.001. Equal numbers of
females and males in this group.
{Chi-square analysis Z/Lhx2:CreER vs. control: p,0.001
doi:10.1371/journal.pgen.1000904.t001
(8-week- and 4-day-old) (F,F’). (H–J) In situ hybridization analyses for GFP expression in HFs from Tx-treated Z/Lhx2-GFP:CreER animals (H,I) and Z/Lhx2-
GFP control mice (J). Most common expression pattern of GFP is in the proximal part of the hair bulb (H, black arrows) and in the ORS (H, arrow
heads). GFP expression was also observed frequently in cells in the IRS (I, red arrows). (K,L) b-Gal staining of HFs in a Tx-treated Z/Lhx2-GFP:CreER (K)
compared to HFs in a Z/Lhx2-GFP control animal (L). Lack of b-Gal
+ cells in the proximal part of the hair bulb is in agreement with that most of the
GFP
+ cells are located at this part of the HF (black arrows). Control HFs contain numerous b-Gal
+ cells in this area (L, black arrows). (M) Expression of
Lhx2 analysed by in situ hybridization in HFs in Tx-treated Z/Lhx2-GFP:CreER mice. Expression is detected in all HFs and also in the IRS where Lhx2 is
not expressed in control animals (red arrows). Scale bars: (A–G,A’–G’) 100 mm, (H–M) 50 mm.
doi:10.1371/journal.pgen.1000904.g005
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pattern suggests that they are highly overlapping and hence
defines a similar, if not an identical, cell population. Our data also
suggest that Lhx2 expression during late telogen might be an
‘‘activation marker’’ of the putative Lgr5
+CD34
2 follicular stem/
progenitor cell population in the secondary HG, and that the
Lhx2
+Lgr5
+CD34
2 cells initiate the anagen phase. Moreover,
recent data also suggests that cells in the secondary HG become
activated during late telogen prior to anagen induction which is
also accompanied by changes in gene expression pattern in the DP
[46], and the expression of Lhx2 might be a part of this process.
The finding that over-expression of Lhx2 in the epidermal part of
the HF is sufficient to prematurely induce anagen is in agreement
with this hypothesis. However, Lhx2 is not required for anagen (or
HF morphogenesis) induction whereas it is required for the
progression of anagen and morphogenesis, revealing that redun-
dant mechanism(s) can compensate for Lhx2 in the initiation
process. The molecular basis of this redundancy in the initiation of
anagen is unknown, but a role of other LIM homeobox genes is
unlikely since the related LIM-homebox genes Lhx9 and Lmx1b,
which can compensate for Lhx2 in limb development [47], are not
expressed in follicular epidermis (unpublished data). It remains to
be elucidated whether or not upregulation of Lhx2 expression
during late telogen is an intrinsic property of the epidermal
Figure 6. Overview of the expression pattern of Lhx2 and a model for the function of Lhx2 in HF morphogenesis and postnatal HF
cycling. Lhx2 is expressed from an early time point during HF morphogenesis in basal keratinocytes before a dermal condensate (dc) is formed
(Stage 0), and is broadly expressed in the epithelial part of the HF in the subsequent stages of morphogenesis. In a fully developed HF (Stage 8 of
morphogenesis), Lhx2 is expressed by cells in the ORS and in the most proximal part of the hair bulb (hb). When the HF enters telogen Lhx2
expression becomes undetectable (Telogen, Early) but expression reappears in CD34
2 cells in the secondary hair germ (2uHG) immediately prior to
anagen induction (Telogen, Late). The pattern of Lhx2 expression during morphogenesis is thereafter reiterated during anagen progression (Sub-
stages I-VI) until the next anagen-catagen-telogen transition occurs and Lhx2 expression is turned off. The conditional inactivation of Lhx2 in
postnatal HFs reveal that these HFs do not develop beyond Sub-stage III of the anagen phase showing that Lhx2 is required to develop further (blue
arrow in anagen progression). The mouse strain homozygous for the hypomorphic allele of Lhx2 (Lhx2
Neo/Neo), revealed that embryonic HFs are
developmentally arrested at an early stage in this loss-of-function model. Since we rarely identified HFs at Stage 5 we suggest that Lhx2 is required to
develop beyond Stage 4 (blue arrow in HF morphogenesis). HFs expressing transgenic Lhx2 (Lhx2-GFP) during postnatal HF cycling can enter catagen
and telogen similar to control HFs, but transgenic Lhx2 expression causes premature initiation of anagen (purple arrows). The cells expressing
transgenic Lhx2 preferentially locate to the proximal part of the hair bulb where the cells expressing endogenous Lhx2 are also located. Since
transgenic expression of Lhx2 appears to induce endogenous Lhx2 expression, we suggest that numerous cells co-express the transgene and the
endogenous gene, particularly in the proximal part of hb. Cells expressing transgenic Lhx2 are also located in the IRS whereas endogenous Lhx2 is
not expressed in this area. 2uHG, secondary hair germ; bu, bulge region; ch, club hair; d, dermis; dc, dermal condensate; DP, dermal papilla; e,
epidermis; hb, hair bulb; HS, hair shaft; IRS, inner root sheath; Me, melanocytes synthesising pigment; Mx, matrix; ORS, outer root sheath.
doi:10.1371/journal.pgen.1000904.g006
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DP, and/or linked to cyclic BMP signalling regulating stem cell
activation [48],
Relatively few cells express the Lhx2 transgene in HFs of Tx-
treated Z/Lhx2-GFP:CreER mice, which might explain why the
HFs can enter telogen phase similar to the control HFs. A more
robust expression of transgenic Lhx2 might give a different
outcome, and this issue is being addressed at present. Moreover,
the ability of cells expressing transgenic Lhx2 to migrate in the
same manner as cells expressing endogenous Lhx2 might also
explain why HFs prematurely initiate a new anagen phase. Thus,
cells expressing transgenic Lhx2 would be close to the DP and
convey epidermal signals to it, similar to the activation of the HG
cells prior to anagen initation [46]. Consequently the DP would
signal back to epidermal cells since continuous signalling between
epidermal cells and DP is required for hair formation [2,10]. This
could, in part, explain why relatively few Lhx2 expressing cells in
postnatal HFs can induce endogenous Lhx2 expression in a cell
nonautonomous manner and initiate anagen prematurely. Thus,
in this mouse model initiation of anagen is promoted whereas the
duration of anagen is not affected.
The Lhx2 loss-of-function models have revealed that Lhx2 is
necessary for the progression of both anagen and morphogenesis.
Since the Hedgehog, Wnt and Nog/BMP signalling pathways are
important for anagen and morphogenesis initiation/progression
[11–14,17,18], we analysed whether any of these pathways were
affected in the mutant HFs. However, no difference in expression
of the central mediators of Nog/BMP, Hedgehog (Shh, Smo, Ptc1)
or Wnt (Lef1) signalling could be observed between control and
mutated HFs. Furthermore, activation of the respective pathways
in mutant HFs was supported by the presence of the stabilized
form of b-catenin that mediates Wnt signalling [49], expression of
Ptc1 that is a downstream transcriptional target gene in Hedgehog
signalling [11,50], and expression of Lef1, which is induced by
Nog [51]. Signalling via NF-kB induced by the Tumour Necrosis
Factor (TNF) family of ligands is also an important pathway
promoting HF morphogenesis [52]. Although we have not directly
analysed this pathway in mutant HFs, it is unlikely that Lhx2 is
involved in this pathway since active NF-kB signalling induces
expression of Shh [53], which is clearly expressed in both the
conditional mutant as well as the hypomorphic mouse strain.
Thus, as far as we can determine, loss of Lhx2 function does not
disturb any major signalling pathway important for anagen
initiation/progression or HF morphogenesis. Moreover, signifi-
cant numbers of proliferating cells are present in the mutated HFs
showing that the developmental arrest at anagen Sub-stage III
cannot solely be due to lack of proliferating cells at this stage. Co-
factor of LIM domain 2 (Clim2) is expressed in the ORS and the
matrix cells and has been shown to physically interact with Lhx2
[54]. Transgenic expression of a dominant negative Clim in the
HF using a K14 promoter leads to a progressive hair loss during
postnatal life due to aberrant HF differentiation and disrupted HF
structure [54], revealing that other means to interfere with Lhx2
function also hampers hair formation. These data suggest that
Lhx2 play a role in the differentiation/patterning of the HFs. Such
a function of Lhx2 has previously been shown in the fetal liver
where Lhx2, both in a cell autonomous and cell nonautonomous
manner, is involved in the expansion, differentiation and
organisation of all cellular components of the liver into a
functional 3-dimensional structure [25]. The exact mechanism(s)
by which Lhx2 can regulate such complex processes in organ
development is a central question in organogenesis.
Our results show that Lhx2 can regulate two separable
processes in HF cycling; firstly, Lhx2 can initiate anagen but it
is not required for this process, secondly, Lhx2 is required for the
progression of anagen (and morphogenesis) generating a fully
assembled hair shaft. These observations indicate a rather complex
role for Lhx2 in HF biology, suggesting that Lhx2 can initiate the
signalling cascades necessary for anagen initiation, as well as
regulate the process of anagen progression and hence hair
formation. The significantly reduced number of HFs in the mouse
strain homozygous for the hypomorphic allele of Lhx2 as well as in
the Lhx2
2/2 mice as previously reported [27], further supports the
idea that Lhx2 has an important function during the early stages of
HF development. We have not yet been able to determine the
molecular basis for Lhx2 activity in the HF. However, we have
previously performed a global gene expression analysis of
hematopoietic stem cell-like cell lines with inducible Lhx2
expression where we could identify 141 genes that correlated to
Lhx2 expression. Gene Ontology classification of these genes
revealed that genes related to ‘regulation of signal transduction’
and ‘organogenesis’ were over-represented [26]. A considerable
fraction of these genes (31%) that we have analysed are expressed
in the HF, for example Nuak1 (NM_001004363), Tmem2
(NM_031997), Etv5 (NM_023794), and Enc1 (NM_007930) [26],
suggesting a putative overlap in Lhx2 function between different
tissues. Further elucidation of the molecular basis of Lhx2 function
in the HFs is important to fully understand the complex regulation
of hair formation.
Materials and Methods
Ethics statement
All experiments involving animals were approved by the Animal
Review Board at Umea ˚ University.
Staging of HFs and timing of the synchronised postnatal
hair cycles on back skin
Staging of hair follicle morphogenesis is according to [28], and
the staging and Sub-stages of postnatal HF cycles and the
nomenclature of HFs used throughout this work are according to
[29]. The initial postnatal hair cycles of back skin HFs in female
C57BL/6 mice are synchronized [29] (Figure S2). Since we have
analysed both female and male mice with a mixed genetic
background (C57BL/6 x 129/Sv), we determined the timing of the
initial postnatal hair cycles in our mouse breeding stock used for
these experiments to exclude any major deviations from what has
been published (summarised in Table S1). The timing of the first
postnatal telogen-anagen transition in 3–4 weeks old mice and the
first postnatal anagen-catagen-telogen transition in 6–8 week old
mice agreed fairly well with previous findings (Table S1; Figure S2)
[29]. Moreover, the HFs on the back skin of most control mice had
entered the second and extended telogen at 7–8 weeks of age
(Table S1). According to [29] (Figure S2), the second postnatal
anagen is initiated at 12 weeks of age but we were unable to define
a synchronized starting point of the second postnatal anagen in
our control animals (Table S1).
Generation and maintenance of mice and tamoxifen-
treatment
All mice were maintained at the animal facility at Umea ˚
University under pathogen-free conditions. Generation of the Z/
Lhx2-GFP transgenic mouse strain was essentially as described
previously for the Z/AP double reporter mouse strain [39], but the
AP part in the Z/AP double reporter vector was replaced by
Lhx2-GFP to generate the Z/Lhx2-GFP vector. E14 ES cells were
electroporated (Bio-Rad GenePulser) with the Z/Lhx2-GFP vector
and G418-resistent cells were selected in 350 mg/mL of G418
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showing the highest b-Gal activity and had a single integration of
the construct was further selected and used for blastocyst injections
at the Umea ˚ Transgene Core Facility (UTCF). Blastocysts were
transferred to pseudo-pregnant females and chimeric offspring
were crossed with C57BL/6 mice to obtain germ-line transmission
of the Z/Lhx2-GFP transgene. The Z/Lhx2-GFP mouse strain with
the highest b-Gal activity in HFs was chosen for further
experiments (Figure S7B and S7C).
The mouse strain with a hypomorphic allele of Lhx2 (Lhx2
Neo)
was generated by inGenious Targeting Laboratory Inc. (www.
genetargeting.com). The presence of the Neo gene in the intact
Lhx2 locus between exon 2 and 3 in the opposite transcriptional
orientation was confirmed by Southern blot analyses on ES cells
and by PCR on tail biopsies (Figure S4A). Mice containing a
floxed allele of Lhx2 were obtained by crossing Lhx2
Neo/+ mice
with mice transgenic for the Flp recombinase as this will generate
offspring where Neo is deleted and leave two loxp sites flanking
exon 2 (Figure S4B). We have also confirmed the phenotype using
another Lhx2
flox mouse strain where exons 2 and 3 are flanked by
loxp sites [32], which are the exons deleted in the conventional
knock-out [22]. The mutated Lhx2 gene is expressed but Lhx2
mRNA missing either exon 2 or exons 2 and 3 are unable to make
Lhx2 protein containing any functional domains since both
transcripts are out-of-frame down-stream of exon 1.
The Z/Lhx2-GFP and CreER [33] transgenes, and the Lhx2
Neo
and Lhx2
flox alleles were maintained on a mixed genetic back-
ground (C57BL/6 X 129/Sv). The Lhx2
flox/flox and Lhx2
flox/- mice
are healthy and fertile. Primers used to identify the Lhx2
Neo and
Lhx2
flox alleles were: DL1 59-GTTCTAGAAGTGGAAGGG-
GAGTGG-39, LOX 59-GCCAGACTAGCAGACGCTGC-39,
SDL2 59-CCACCGGTACTCCTCTTCAGAG-39, UNI 59-AG-
CGCATCGCCTTCTATCGCCTTC-39, AT1 59-CACTCCGA-
GCCTGTTTGGTG-39. Primers used to identify the Z/Lhx2-
GFP transgene were GFPforward 59-TTCCACCATATTGCC-
GTC-39 and GFPreverse 59-AGAACTTGCCGCTGTTCA -39.
The morning of the vaginal plug was considered as E0.5. Dorsal
(back) skin was shaved with electric razor and 1 mg of 4-
hydroxytamoxifen (Sigma H7904) dissolved in acetone was
applied to the shaved area once a day for 7–9 consecutive days.
Histology, in situ hybridization, b-gal staining, alkaline
phosphatase staining, and immunofluoresence
Skin was isolated and fixed in 4% paraformaldehyde (PFA) in
PBS at 4uC, transferred to 30% sucrose in PBS for 24 hours at
4uC, mounted in Tissue-Tek (Sakura) and stored at 280uC.
Sectioning (8 mm) was performed in a cryostat (Microm HM505E)
and collected on Superfrost Plus slides (Menzel-Gla ¨ser). For
hematoxylin-eosin staining tissue sections were incubated in
Mayer’s hematoxylin solution for 2 min, water 15 min, eosin
solution 2 min, 95% ethanol 261 min, 99% ethanol 261 min and
in xylene for 5 min. The slides were mounted with DPX mounting
media (VWR).
For b-Gal staining skin tissue fixed for 30 min in PFA was
cryosectioned, washed for 3620 min in wash buffer (0.1M
phosphate buffer, 2 mM MgCl2, 5 mM EGTA, 0.02% NP40
and 0.01% sodium deoxycholate) and subsequently incubated in
wash buffer supplemented with 1 mg/ml 5-bromo-4-chloro-3-
indolyl-D-galactopyranoside (X-gal, Austral), 5 mM potassium
ferrocyanide and 5 mM potassium ferricyanide, for 4–8 hours at
room temperature. The reaction was stopped with 365 min
washes with PBS, and sections were mounted in 87% glycerol.
In situ hybridization using DIG labelled probes was performed
essentially as described previously [55,56]. Skin fixed in PFA for
24 hours was sectioned and treated with 10 ml/ml proteinase K
(Roche) in 0.1 M PBS for 15 min at room temperature prior to
hybridization. The DIG-signal was visualized with AP-conjugated
anti-DIG Fab2 fragments and developed using NBT and BCIP
(Roche). The following probes were used: Lhx2 (NM_010710,
full length cDNA nucleotides 460–1750, exon 2 nucleotides
587–789, exon 2–3 nucleotides 643–1172), GFP (hrGFP, complete
coding region), Shh (NM_017221, nucleotides 1–1715), Smo
(NM_176996, nucleotides 2957–3813), Ptc1 (NM_008957, nucle-
otides 1–841), Lef1 (BC057543, nucleotides 1678–2999), BMP4
(NM_007554, nucleotides 117–578), and Hist1h3c (NM_175653,
nucleotides 27–480).
Immunohistochemistry was performed essentially as previously
described [57]. Skin fixed for 30 min or 2 hours was sectioned and
slides were washed 365 min in TBS (50 mM Tris-HCl pH 7.4,
150 mM NaCl) and blocked with 10% FCS in TBST (TBS with
0.1% Triton X-100) for 20 min. The primary antibodies rat anti-
CD34 (MEC 14.7, Abcam, dilution 1:50) and rat anti-E-cadherin
(Zymed Laboratories Inc., dilution 1:300) were applied to slides
over night at 4uC diluted in TBST with 5% FCS. After 365 min
washing in TBST, the secondary antibody, donkey anti-rat IgG
labelled with Alexa Fluor 488 (Molecular Probes, dilution 1:400),
was added together with DAPI for 1 hour at room temperature.
The primary rabbit anti-mouse Lhx2 (generous gift from Dr.
Sara Wilson, dilution 1:32,000) was applied to slides over night.
After 365 min washing in TBST, the secondary antibody, Cy3-
conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch
Laboratories Inc., dilution 1:400), was added together with DAPI
for 1 hour at room temperature. Slides were subsequently washed
365 min in TBST before mounting with fluorescence mounting
medium (Vectashield, Vector Laboratories). For the immunolabel-
ling of the active (dephosphorylated) form of b-catenin, skin fixed
for 2 hours was used. Slides were washed 365 min in TBST,
blocked for endogenous peroxidase activity in 2% H2O2, 80%
methanol for 20 min, washed, incubated in citrate buffer (10 mM
sodium citrate, pH 6.0) at 95uC for 20 min for epitope retrieval
and washed. After blocking with 10% FCS in TBST for 1 hour,
the primary mouse anti-b-catenin antibody (Upstate 05-665,
dilution 1:400, recognise non-phosphorylated Ser-37 and Thr-41)
was applied to the slides over night at 4uC. After washing, the
slides were exposed to the secondary biotinylated anti-mouse
antibody (dilution 1:400) for 2 hours at room temperature, washed
and incubated for 1 hour in Avidin-Biotin Complex (ABC)
solution (Vector; 2% buffer A, 2% buffer B and 10% FCS in
TBST), washed 365 min in TBST and developed in DAB-
solution (Sigma) with 0,01% H2O2 for 5 min. After thorough
washing in cold PBS, the slides were mounted in 87% glycerol.
Skin fixed in PFA was used for detection of AP activity. The
sections were fixated in acetone at 220uC for 5 min, washed for
365 min in PBS, rinsed 5 min in TN buffer pH 9.5 (0.1 M Tris-
HCl, 0.1 M NaCl) and exposed to 125.6 mg/ml NBT and 63 mg/
ml BCIP in TN buffer for 20 min in darkness. Sections were
washed with PBS 365 min to stop the reaction and subsequently
mounted in 87% glycerol.
The number of HFs in embryos was calculated from two
sections from two different control embryos and two sections from
two different Lhx2
Neo/Neo embryos at E16.5, and four sections from
two control animals and two sections from two Lhx2
Neo/Neo embryos
at E18.5.
Statistical analyses
Statistical analyses were carried using Student’s t-test or the
Chi-square method.
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Figure S1 Lhx2 expression in whisker HFs mimics the expression
pattern in pelage HF. (A) In situ hybridization analysis reveals Lhx2
expression in the ORS (arrow heads) and in matrix cells in the
proximal part of the hair bulb (arrows) during whisker HF
morphogenesis. (B) In situ hybridization analysis reveals Lhx2
expression in the ORS (arrow heads) and in matrix cells in the
proximal part of the hair bulb (arrows) in an adult whisker HF. Scale
bar, 100 mm.
Found at: doi:10.1371/journal.pgen.1000904.s001 (1.41 MB TIF)
Figure S2 Time scale for the first postnatal and synchronized
HF cycles in female C57BL/6 mice, and an overview of the
strategy to conditionally inactivate the Lhx2 gene or induce
transgenic expression of Lhx2. The time scale to illustrate the
temporal progression through the postnatal HF cycles is adapted
from [29]. The Lhx2 gene was conditionally inactivated by treating
shaved back skin on CreER:Lhx2
flox/flox and CreER:Lhx2
flox/- mice
with Tx during the first postnatal telogen phase in approximately
3-week-old mice (indicated by the first red bar between week 3 and
4). The progression of the first postnatal anagen phase was
analysed in these mice and control Lhx2
flox/flox and Lhx2
flox/-
animals at 5.5 to 6 weeks of age (indicated by the second red bar
between week 5 and 6). To induce transgenic expression of Lhx2
in postnatal HFs the CreER:Z/Lhx2-GFP double transgenic mice
were shaved on the back skin and treated with Tx in
approximately 5 weeks old mice (indicated by the first yellow
bar at 5 weeks). The effect of transgenic Lhx2 expression was
analysed and compared to control single transgenic mice (CreER or
Z/Lhx2-GFP) during the extended telogen phase at 8–9 weeks of
age (indicated by the second yellow bar between week 8 and 9).
Found at: doi:10.1371/journal.pgen.1000904.s002 (0.10 MB TIF)
Figure S3 Over-view of Lhx2 expression pattern of HFs in early
telogen, late telogen and early anagen Sub-stages I/II and III. (A)
Analysis of Lhx2 expression in HFs in early telogen (3-week- and
1-day-old mice). Most mice at this age have their HFs in telogen
(Table S1). No expression can be detected in any HF at this stage.
(B) Analysis of Lhx2 expression in HFs in telogen in late telogen (3
week and 4 days old mice). Numerous mice have initiated anagen
at this age (Table S1). Homogenous and distinct expression is
detected in the secondary HG of all HFs at this stage (arrows). Shh
is not expressed in HFs at this stage confirming that HFs are in
telogen (Figure 2I). (C) Analysis of Lhx2 expression in HFs in
anagen Sub-stages I-II (prior to pigment deposition). Lhx2
expression is detected in all HFs in the secondary HG and most
epithelial cells in the down-growing part of the HF. Shh is
expressed in all HFs at this stage (Figure 2M). (D) Analysis of Lhx2
expression in HFs in anagen Sub-stage III (all HFs contain
pigment and most hair shaft has not reached the hair canal). Lhx2
expression is detected in cells in the ORS (arrow heads) and the
proximal part of the hair bulb (arrows). Scale bar, 100 mm.
Found at: doi:10.1371/journal.pgen.1000904.s003 (4.19 MB TIF)
Figure S4 Description of the mouse strains with a hypomorphic
allele of Lhx2 (Lhx2
Neo), and a floxed allele of Lhx2 (Lhx2
flox). (A)
Description of the hypomorphic allele of Lhx2 locus containing the
Neo gene between exon 2 and 3 in the opposite transcriptional
orientation (upper panel). The location of the primers used to identify
the WT allele and the Lhx2
Neo allele are indicated (upper panel) and
the PCR results to identify mice that are WT, heterozygous or
homozygous for the Lhx2
Neoallele are shown (lower panel). loxsites are
indicated by black triangles and Flp sites are indicated by white arrow
heads. (B) Description of the ‘‘floxed’’ Lhx2 allele (Lhx2
flox)a f t e rF l p -
mediated deletion of the Neo gene (upper panel). The location of the
primers used to identify the Lhx2
flox allele are indicated (upper panel)
and the PCR results to distinguish mice that have the Lhx2
Neo allele or
the Lhx2
flox allele are shown (lower panel). (C) Comparison between
an E18.5 control embryo (left) and an Lhx2
Neo/Neo embryo (right). The
Lhx2
Neo/Neo embryos develop the same eyeless phenotype as the
Lhx2
2/2 embryos confirming that Lhx2 expression is significantly
decreased. However, the anemia in Lhx2
Neo/Neo e m b r y o si sl e s ss e v e r e
compared to the Lhx2
2/2 embryos and the expected number of live
embryos can therefore be obtained at E18.5 when pelage HF
morphogenesis is well established.
Found at: doi:10.1371/journal.pgen.1000904.s004 (0.88 MB TIF)
Figure S5 Conditional inactivation of Lhx2 is incomplete in Tx-
treated CreER:Lhx2
flox/flox mice leading to re-growth of some hair.
In situ hybridization analyses on HFs from the shaved and Tx-
treated area on CreER:Lhx2
flox/flox mouse where hair started to re-
grow. (A) In situ hybridization using the full length Lhx2 probe
that detects both the WT allele and the mutant allele. (B) In situ
hybridization using the probe restricted to exon 2 that only detects
the WT allele (arrows), revealing incomplete inactivation of the
Lhx2 gene leading to rescue of hair growth.
Found at: doi:10.1371/journal.pgen.1000904.s005 (2.53 MB TIF)
Figure S6 The S-phase-specific histone gene Hist1h3c is only
expressed during anagen. In situ hybridization analyses of Hist1h3c
expression of HFs in telogen (A) and anagen (B). (C) Hist1h3c is
expressed in anagen HFs where Lhx2 has been conditionally
inactivated in a similar pattern as in control HFs.
Found at: doi:10.1371/journal.pgen.1000904.s006 (1.20 MB TIF)
Figure S7 Generation of a transgenic mouse strain where Lhx2
expression canbe inducedinpostnatalHF epidermis. (A)Schematic
representation of the vector used to generate the Z/Lhx2-GFP
transgenic mouse strain (upper panel) and the organisation of this
vector after Cre-mediated recombination (lower panel). The blue
arrows correspond to the mRNA that is generated before and after
Cre-mediated recombination of this vector. The expression system
isbasedontheZ/APdoublereportervector developedbyLobe and
co-workers [39], where a floxed allele of b-Geo (encoding a b-
galactosidase-Neomycin fusion protein) is followed by an expression
cassette consisting of the Lhx2 cDNA, an internal ribosomal entry
site (IRES) and green fluorescent protein (GFP) cDNA. Thus, DNA
recombination by the Cre recombinase will delete the b-Geo gene
and place Lhx2-GFP immediately downstream of the promoter/
enhancer leading to its transcription. We generated a mouse strain
transgenic for this vector (Z/Lhx2-GFP) that showed b-Gal activity
in a variety of tissues including epidermis and in the epithelial
portion ofHFsintelogen (B) aswell asanagen (C).TheZ/Lhx2-GFP
mouse strain was crossed with the CreER transgenic mouse strain
where Tx-treatment of skin of the Z/Lhx2-GFP:CreER double
transgenic mice will lead to activation of Lhx2 expression in HFs.
Found at: doi:10.1371/journal.pgen.1000904.s007 (1.18 MB TIF)
Table S1 Hair cycle stage of back skin HFs in control mice at
different ages.
Found at: doi:10.1371/journal.pgen.1000904.s008 (0.10 MB
PDF)
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